Skip to content

RSA-Study of Cemented Hip Prostheses With Five Different Articulations

A Prospective Randomized RSA-Study of Cemented Hip Prostheses With Five Different Articulations

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00698672
Enrollment
150
Registered
2008-06-17
Start date
2004-11-30
Completion date
2017-06-30
Last updated
2017-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis

Keywords

RSA

Brief summary

The purpose of this study is to compare wear and migration of the following hip prostheses: 1. Charnley monoblock 22.2mm caput and OGEE polyethylene acetabular component 2. Spectron EF stem with Reflection polyethylene cup and 28 mm CoCr caput 3. Spectron EF stem with XLPE cup and 28 mm CoCr caput 4. Spectron EF stem with Reflection polyethylene cup and 28 mm Oxinium caput 5. Spectron EF stem with XLPE cup and 28 mm Oxinium caput

Detailed description

Detailed description in: Wear and migration of highly cross-linked and conventional cemented polyethylene cups with cobalt chrome or Oxinium femoral heads: a randomized radiostereometric study of 150 patients. Kadar T, Hallan G, Aamodt A, Indrekvam K, Badawy M, Skredderstuen A, Havelin LI, Stokke T, Haugan K, Espehaug B, Furnes O. J Orthop Res. 2011 Aug;29(8):1222-9. doi: 10.1002/jor.21389

Interventions

DEVICEcharnley OGEE

charnley OGEE

DEVICESpectron Reflection CoCr

Spectron Reflection CoCr

DEVICESpectron XLPE CoCr

Spectron XLPE CoCr

DEVICESpectron Reflection Oxinium

Spectron Reflection Oxinium

DEVICESpectron XLPE CoCR

Spectron XLPE CoCR

Sponsors

Haukeland University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
59 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* arthritis * dysplasia

Exclusion criteria

* obesitas * charcots * paget * malignancy

Design outcomes

Primary

MeasureTime frame
wear2 years

Secondary

MeasureTime frame
migration2 years

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026